TY - JOUR
T1 - Aggressive B-cell lymphoma cases with 11q aberration patterns indicate a spectrum beyond Burkitt-like lymphoma
AU - Gebauer, Niklas
AU - Witte, Hanno M.
AU - Merz, Hartmut
AU - Oschlies, Ilske
AU - Klapper, Wolfram
AU - Caliebe, Almuth
AU - Tharun, Lars
AU - Spielmann, Malte
AU - Von Bubnoff, Nikolas
AU - Feller, Alfred C.
AU - Murga Penas, Eva M.
N1 - Publisher Copyright:
© 2021 American Society of Hematology. All rights reserved.
PY - 2021/12/14
Y1 - 2021/12/14
N2 - The recent characterization of a group of non-MYC rearranged aggressive B-cell lymphomas, resembling Burkitt lymphoma (BL), characteristically harboring a telomeric 11q loss or combined 11q proximal gains/loss pattern has led to the introduction of the provisional entity of Burkitt-like lymphoma with 11q aberration (BLL-11q). Prompted by the discovery of a telomeric 11q loss in an HIV1 high-grade B-cell lymphoma patient, we investigated an extended cohort of aggressive B-cell lymphomas, enriched for cases with histopathological features intermediate between DLBCL and BL, including double- and triple-hit lymphomas (n 5 47), for 11q loss/combined 11q proximal gains/loss pattern by fluorescence in situ hybridization. Weprovide first evidence that 11q aberrations can be found in both BLL in the context of an underlying HIV infection as well as in high-grade B-cell lymphomas with MYC, BCL2, and/or BCL6 rearrangements. We therefore propose that the clinicopathological spectrum ofmalignancies carrying this aberration may be broader than previously assumed.
AB - The recent characterization of a group of non-MYC rearranged aggressive B-cell lymphomas, resembling Burkitt lymphoma (BL), characteristically harboring a telomeric 11q loss or combined 11q proximal gains/loss pattern has led to the introduction of the provisional entity of Burkitt-like lymphoma with 11q aberration (BLL-11q). Prompted by the discovery of a telomeric 11q loss in an HIV1 high-grade B-cell lymphoma patient, we investigated an extended cohort of aggressive B-cell lymphomas, enriched for cases with histopathological features intermediate between DLBCL and BL, including double- and triple-hit lymphomas (n 5 47), for 11q loss/combined 11q proximal gains/loss pattern by fluorescence in situ hybridization. Weprovide first evidence that 11q aberrations can be found in both BLL in the context of an underlying HIV infection as well as in high-grade B-cell lymphomas with MYC, BCL2, and/or BCL6 rearrangements. We therefore propose that the clinicopathological spectrum ofmalignancies carrying this aberration may be broader than previously assumed.
UR - http://www.scopus.com/inward/record.url?scp=85121670309&partnerID=8YFLogxK
U2 - 10.1182/bloodadvances.2021004635
DO - 10.1182/bloodadvances.2021004635
M3 - Journal articles
C2 - 34500469
AN - SCOPUS:85121670309
SN - 2473-9529
VL - 5
SP - 5220
EP - 5225
JO - Blood Advances
JF - Blood Advances
ER -